Virax Biolabs Group Limited (VRAX:NASDAQ) shot up at $5.57, a gain of 58.7%. On Thu, Sep 01, 2022, VRAX:NASDAQ hit a New 2-Week High of $5.57. The stock appeared on our News Catalysts scanner on Tue, Aug 16, 2022 at 10:18 AM in the 'PUBLIC OFFERING' category. From Thu, Aug 18, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Jul 29, 2022 at $29 with a volume of 10M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Hempacco Co. Inc. (HPCO:NASDAQ), 63.41%
- GigaCloud Technology Inc (GCT:NASDAQ), 61.43%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 58.69%
- Forma Therapeutics Holdings Inc. (FMTX:NASDAQ), 51.04%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- ShiftPixy, Inc. (PIXY:NASDAQ), 46.9%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 36.17%
- Kuke Music Holding Limited American Depositary Shares each representing one (KUKE:NYSE), 32.94%
- Nutanix, Inc. (NTNX:NASDAQ), 29.13%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 28.57%